Tracking trends in healthcare, from tech to patient care

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Every year, the Healthcare Businesswomen’s Association, a nonprofit organization whose core purpose is to further the advancement and impact of women in the healthcare business, honors a wide array of executives. Last week, we talked to some … Read more

Sigma-Aldrich Files Reply to Broad’s Opposition to Sigma’s Substantive Preliminary Motion No. 1 to Deny Priority Benefit in Interference No. 106,133

By Kevin E. Noonan — On December 3rd, Senior Party Sigma-Aldrich filed its Preliminary Motion No. 1 that asked the Board to deny the Broad Institute, Harvard University, and MIT (collectively, Broad) benefit of its US Provisional Application No. 61/736,527, filed December 12, 2012 (termed “P1”), pursuant to 37 CFR § 41.121(a)(1) and SO ¶¶ … Read more

A potential COVID-19 EUA could turn this small biotech into a household name

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. It’s not a done deal. But so far, all indications point to the probability of Veru, a small biotech, winning the latest Emergency Use Authorization from the FDA for a COVID-19 treatment. And if all goes well, … Read more

Ironwood Pharmaceuticals is charting a course to become a giant in GI

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Rain, shine or blizzard, Tom McCourt always made a point to walk home through the streets of Cambridge, Mass., alongside his coworker at Ironwood Pharmaceuticals, then chief scientific officer, Mark Currie, during his early years as chief … Read more

Jumping into pharma with big plans at a small company

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Turning 50 does different things to people. Some people buy sports cars. Others start thinking about all the vacations they didn’t take or all the novels they never wrote. Jim Cassidy decided to join the pharma industry. … Read more

Biotech Spotlight: Graphite Bio seeks sickle cell cure with a next-gen approach

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Welcome to Biotech Spotlight, a series featuring companies with breakthrough technologies and strategies. Today, we’re looking at Graphite Bio, a gene editing company advancing a treatment for sickle cell disease that makes use of precise methods of … Read more

ELITE 2022 Uber Winner Mikael Dolsten of Pfizer

Mikael Dolsten, MD, PhD Chief Scientific Officer and President, Worldwide Research, Development, and Medical Pfizer Inc. Act like you are NASA and shoot for the moon. That was the mindset that helped Pfizer, along with partner BioNTech, to develop the first vaccine for COVID-19—one that hit the market in record time, was the first vaccine … Read more

CVC Files Reply to Sigma-Aldrich Opposition to CVC’s Responsive Motion No. 1

By Kevin E. Noonan — Pursuant to the Patent Trial and Appeal Board Order issued November 29, 2021, Junior Party the University of California, Berkeley; the University of Vienna; and Emmanuelle Charpentier (collectively, “CVC”) on December 17, 2021 filed its Responsive Preliminary Motion No. 1 in Interference No. 106,132 (which names Sigma-Aldrich as Senior Party), … Read more